Novartis AG
SIX:NOVN
Novartis AG
SIX:NOVN
Price:
88.1 CHF
0.15%
Market Closed
Updated:
May 7, 2024
Novartis AG
Operating Income
|
Novartis AG
Operating Income Peer Comparison
Comparables:
NLSP
ROG
S
SDZ
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novartis AG
SIX:NOVN
|
Operating Income
$12.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Operating Income
-$15.5m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Roche Holding AG
SIX:ROG
|
Operating Income
CHf18.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Operating Income
$1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novartis AG's Operating Income?
Operating Income
12.6B
USD
12.6B
USD
Based on the financial report for Dec 31, 2023, Novartis AG's Operating Income amounts to 12.6B USD.
What is Novartis AG's Operating Income growth rate?
Operating Income CAGR 10Y
1%
1%
Over the last year, the Operating Income growth was 24%. The average annual Operating Income growth rates for Novartis AG have been 1% over the past three years , 5% over the past five years , and 1% over the past ten years .
You don't have any saved screeners yet
